TAUNS Laboratories Inc (197A) Stock Price & News

197A:TYO

TAUNS Laboratories Inc

¥480.00

-1.23%

(-6.00) 1D

Nov 4, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 197A...

Open

¥486

High

¥488

Low

¥478

Mkt. cap

51.27B

Avg. vol.

184.90K

Volume

183.50K

Dividend

5.83%

Quarterly dividend

¥7

Ex-dividend date

Dec 29, 2026

P/E ratio

9.40

52-wk high

¥577

52-wk low

¥463

EPS

¥51

No. of employees

316

Open

¥486

High

¥488

Low

¥478

Mkt. cap

51.27B

Avg. vol.

184.90K

Volume

183.50K

Dividend

5.83%

Quarterly dividend

¥7

Ex-dividend date

Dec 29, 2026

P/E ratio

9.40

52-wk high

¥577

52-wk low

¥463

EPS

¥51

No. of employees

316

Related stocks

Septeni Holdings Co Ltd

News stories

From web sources and news partners

FinancialContent

17 minutes ago

U.S. Physical Therapy (NYSE:USPH) reports strong Q3 2026

MarketWatch

57 minutes ago

Dow scores its best day in 18 months in a broad relief rally after Democrats sweep to power in Congress

shattered.io

24 minutes ago

S&P Earnings Jump 30.2% as Big Tech Cash Flow Sinks [2026]

PBS

1 hour ago

U.S. stocks surge, and the Dow soars 1,500 points as Brent oil's price drops below $95 per barrel

About TAUNS Laboratories Inc

CEO-

Employees316

FoundedApr 14, 2016

Headquarters-

SectorMedical device

Industry-

Websitetauns.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.37B	5.91B	2.39B	3.71B
Cost of goods sold	738.40M	1.91B	975.84M	1.93B
Cost of revenue	738.40M	1.91B	975.84M	1.93B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.08B	1.30B	1.15B	562.14M
Operating expense	1.08B	1.30B	1.15B	1.09B
Total operating expenses	1.82B	3.20B	2.13B	3.02B
Operating income	547.52M	2.70B	257.70M	690.43M
Other non operating income	-20.00K	-2.98M	413.16M	3.95B
EBT including unusual items	506.19M	2.40B	601.46M	4.39B
EBT excluding unusual items	505.33M	2.64B	611.80M	4.56B
Income tax expense	148.28M	697.27M	218.44M	1.34B
Effective tax rate	29.29%	29.05%	36.32%	30.46%
Other operating expenses	-	-	-	-
Net income	357.90M	1.70B	383.02M	3.05B
Net profit margin	15.11%	28.82%	16.05%	82.35%
Earnings per share	-	-	-	-
Interest and investment income	8.58M	767.00K	13.49M	981.00K
Interest expense	-50.75M	-61.20M	-72.56M	-79.53M
Net interest expenses	-42.17M	-60.43M	-59.07M	-78.55M
Depreciation and amortization charges	-	-	-	527.20M
EBITDA	726.38M	2.90B	436.56M	971.69M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything